Diseases, Conditions, Syndromes

Coronavirus treatments: some progress, no panacea

The pandemic has seen unprecedented global efforts to discover a safe and effective treatment, either by developing new medicines to target the novel coronavirus or repurposing existing drugs.

Diseases, Conditions, Syndromes

In recovering COVID-19 patients, antibodies fade quickly

In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients. The blood of recovered patients contains antibodies ...

Diseases, Conditions, Syndromes

SARS-CoV-2 antibodies provide lasting immunity

One of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how long.

Immunology

The making of memory B cells and long-term immune responses

The current COVID-19 climate has made vaccines, antibodies and immune responses topics of everyday conversation. Now, it isn't just immunologists who want to know how our bodies respond to re-infections months, years, or ...

Diseases, Conditions, Syndromes

Trump-touted COVID-19 antibody treatments: what we know

Two US companies have applied for emergency approval for their lab-produced antibodies against COVID-19—and President Donald Trump has signaled his strong backing based on the fact he was treated with one of them.

Diseases, Conditions, Syndromes

Researchers identify new target for creating flavivirus vaccines

The results of a recent study moved University of Arizona Health Sciences researchers one step closer to developing effective vaccinations against flaviviruses, which infect more than 400 million people a year with diseases ...

page 28 from 40